Rocacetrapib is under investigation in clinical trial NCT02156544 (Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.